Tumor Targeting in Cancer Therapy (Paperback, Softcover reprint of hardcover 1st ed. 2002)


In Tumor Targeting in Cancer Therapy, Dr. Michel Page and a panel of authoritative experts from the drug industry, clinics, and academia introduce the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside. By concisely synthesizing the many technical details, the authors illuminate this innovative technique, ranging from the fundamentals of drug targeting and in vivo and in vitro experimentation, to such emerging therapeutic uses as radioimmunotherapy, radioimmunodetection, therapy with cytotoxic antibodies, immunotoxins, enzyme prodrug immunotherapy, and immunotherapeutics with fusion proteins. There are also reviews of targeting tumors with radioimmunoconjugates, photodynamic therapy, and magnetic drugs, as well as discussions of the internalization of antibodies, bioconjugation and biodistribution, the use of cytotoxic drugs, and the pros and cons of targeting by antibody or ligand.

R5,944

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles59440
Mobicred@R557pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 10 - 15 working days



Product Description

In Tumor Targeting in Cancer Therapy, Dr. Michel Page and a panel of authoritative experts from the drug industry, clinics, and academia introduce the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside. By concisely synthesizing the many technical details, the authors illuminate this innovative technique, ranging from the fundamentals of drug targeting and in vivo and in vitro experimentation, to such emerging therapeutic uses as radioimmunotherapy, radioimmunodetection, therapy with cytotoxic antibodies, immunotoxins, enzyme prodrug immunotherapy, and immunotherapeutics with fusion proteins. There are also reviews of targeting tumors with radioimmunoconjugates, photodynamic therapy, and magnetic drugs, as well as discussions of the internalization of antibodies, bioconjugation and biodistribution, the use of cytotoxic drugs, and the pros and cons of targeting by antibody or ligand.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

HumanaPress

Country of origin

United States

Series

Cancer Drug Discovery and Development

Release date

November 2010

Availability

Expected to ship within 10 - 15 working days

First published

2002

Editors

Dimensions

254 x 178 x 24mm (L x W x T)

Format

Paperback

Pages

463

Edition

Softcover reprint of hardcover 1st ed. 2002

ISBN-13

978-1-61737-251-3

Barcode

9781617372513

Categories

LSN

1-61737-251-X



Trending On Loot